{"entity":{"type":"insider","cik":"0001527497","url":"/insider/0001527497","json_url":"/insider/0001527497.json","name":"Farmer Ronald Harold","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":13,"first":"2011-08-11","last":"2015-10-22","span_basis":"filed_date"},"name_variants":[{"name":"Farmer Ronald Harold","source":"filing","n_filings":13,"first_seen":"2011-08-11","last_seen":"2015-10-22"}],"transactions":[{"id":8653077,"accession":"0000885590-15-000075","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000885590-15-000075","line_url":"/filing/0000885590-15-000075","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001527497","owner_name":"Farmer Ronald Harold","owner_display_name":"Farmer Ronald Harold","owner_url":"/insider/0001527497","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":181.59666666666666,"price_display":"181.60","price_state":"stated","total_value":272395.0,"total_display":"272,395.00","total_whole":"272,395","shares_owned_after":15032.0,"shares_owned_after_display":"15,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-21","filed_date":"2015-10-22","scope":"insider","n_lines":2},{"id":8436607,"accession":"0000885590-15-000067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-15-000067","line_url":"/filing/0000885590-15-000067#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001527497","owner_name":"Farmer Ronald Harold","owner_display_name":"Farmer Ronald Harold","owner_url":"/insider/0001527497","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":220.0,"price_display":"220.00","price_state":"stated","total_value":110000.0,"total_display":"110,000.00","total_whole":"110,000","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-26","filed_date":"2015-08-27","scope":"insider"},{"id":8514721,"accession":"0000885590-15-000066","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000885590-15-000066","line_url":"/filing/0000885590-15-000066","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001527497","owner_name":"Farmer Ronald Harold","owner_display_name":"Farmer Ronald Harold","owner_url":"/insider/0001527497","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":224.973,"price_display":"224.97","price_state":"stated","total_value":224973.0,"total_display":"224,973.00","total_whole":"224,973","shares_owned_after":1500.0,"shares_owned_after_display":"1,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-21","filed_date":"2015-08-25","scope":"insider","n_lines":2},{"id":8707222,"accession":"0000885590-15-000049","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000885590-15-000049","line_url":"/filing/0000885590-15-000049#line-2","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001527497","owner_name":"Farmer Ronald Harold","owner_display_name":"Farmer Ronald Harold","owner_url":"/insider/0001527497","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":232.05,"price_display":"232.05","price_state":"stated","total_value":116025.0,"total_display":"116,025.00","total_whole":"116,025","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-06-09","filed_date":"2015-06-10","scope":"insider"},{"id":8707221,"accession":"0000885590-15-000049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-15-000049","line_url":"/filing/0000885590-15-000049#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001527497","owner_name":"Farmer Ronald Harold","owner_display_name":"Farmer Ronald Harold","owner_url":"/insider/0001527497","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":289.2,"price_display":"289.20","price_state":"stated","total_value":144600.0,"total_display":"144,600.00","total_whole":"144,600","shares_owned_after":35426.0,"shares_owned_after_display":"35,426","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-08","filed_date":"2015-06-10","scope":"insider"},{"id":6329862,"accession":"0000885590-14-000081","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-14-000081","line_url":"/filing/0000885590-14-000081#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001527497","owner_name":"Farmer Ronald Harold","owner_display_name":"Farmer Ronald Harold","owner_url":"/insider/0001527497","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":160.48,"price_display":"160.48","price_state":"stated","total_value":80240.0,"total_display":"80,240.00","total_whole":"80,240","shares_owned_after":33004.0,"shares_owned_after_display":"33,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-12","filed_date":"2014-12-16","scope":"insider"},{"id":6951937,"accession":"0000885590-14-000078","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-14-000078","line_url":"/filing/0000885590-14-000078#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001527497","owner_name":"Farmer Ronald Harold","owner_display_name":"Farmer Ronald Harold","owner_url":"/insider/0001527497","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":163.95,"price_display":"163.95","price_state":"stated","total_value":163950.0,"total_display":"163,950.00","total_whole":"163,950","shares_owned_after":32504.0,"shares_owned_after_display":"32,504","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-24","filed_date":"2014-12-01","scope":"insider"},{"id":4852874,"accession":"0000885590-13-000097","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-13-000097","line_url":"/filing/0000885590-13-000097#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001527497","owner_name":"Farmer Ronald Harold","owner_display_name":"Farmer Ronald Harold","owner_url":"/insider/0001527497","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":107.98,"price_display":"107.98","price_state":"stated","total_value":161970.0,"total_display":"161,970.00","total_whole":"161,970","shares_owned_after":27808.0,"shares_owned_after_display":"27,808","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-06","filed_date":"2013-11-08","scope":"insider"},{"id":5239552,"accession":"0000885590-13-000077","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000885590-13-000077","line_url":"/filing/0000885590-13-000077#line-3","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001527497","owner_name":"Farmer Ronald Harold","owner_display_name":"Farmer Ronald Harold","owner_url":"/insider/0001527497","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":99.99,"price_display":"99.99","price_state":"stated","total_value":49995.0,"total_display":"49,995.00","total_whole":"49,995","shares_owned_after":26057.0,"shares_owned_after_display":"26,057","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-28","filed_date":"2013-08-29","scope":"insider"},{"id":5239547,"accession":"0000885590-13-000077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000885590-13-000077","line_url":"/filing/0000885590-13-000077","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001527497","owner_name":"Farmer Ronald Harold","owner_display_name":"Farmer Ronald Harold","owner_url":"/insider/0001527497","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":102.95,"price_display":"102.95","price_state":"stated","total_value":205900.0,"total_display":"205,900.00","total_whole":"205,900","shares_owned_after":24557.0,"shares_owned_after_display":"24,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-27","filed_date":"2013-08-29","scope":"insider","n_lines":2},{"id":3045202,"accession":"0000885590-12-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-12-000031","line_url":"/filing/0000885590-12-000031#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001527497","owner_name":"Farmer Ronald Harold","owner_display_name":"Farmer Ronald Harold","owner_url":"/insider/0001527497","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":49.34,"price_display":"49.34","price_state":"stated","total_value":98680.0,"total_display":"98,680.00","total_whole":"98,680","shares_owned_after":10847.0,"shares_owned_after_display":"10,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-17","filed_date":"2012-05-21","scope":"insider"},{"id":9058707,"accession":"0000885590-11-000065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-11-000065","line_url":"/filing/0000885590-11-000065#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001527497","owner_name":"Farmer Ronald Harold","owner_display_name":"Farmer Ronald Harold","owner_url":"/insider/0001527497","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":39.72,"price_display":"39.72","price_state":"stated","total_value":39720.0,"total_display":"39,720.00","total_whole":"39,720","shares_owned_after":8209.0,"shares_owned_after_display":"8,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-12","filed_date":"2011-09-14","scope":"insider"},{"id":9201752,"accession":"0000885590-11-000062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-11-000062","line_url":"/filing/0000885590-11-000062#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001527497","owner_name":"Farmer Ronald Harold","owner_display_name":"Farmer Ronald Harold","owner_url":"/insider/0001527497","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":38.57,"price_display":"38.57","price_state":"stated","total_value":38570.0,"total_display":"38,570.00","total_whole":"38,570","shares_owned_after":7209.0,"shares_owned_after_display":"7,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-19","filed_date":"2011-08-24","scope":"insider"},{"id":9010416,"accession":"0000885590-11-000060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-11-000060","line_url":"/filing/0000885590-11-000060#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001527497","owner_name":"Farmer Ronald Harold","owner_display_name":"Farmer Ronald Harold","owner_url":"/insider/0001527497","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":38.57,"price_display":"38.57","price_state":"stated","total_value":38570.0,"total_display":"38,570.00","total_whole":"38,570","shares_owned_after":6209.0,"shares_owned_after_display":"6,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-19","filed_date":"2011-08-23","scope":"insider"},{"id":8952084,"accession":"0000885590-11-000053","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000885590-11-000053","line_url":"/filing/0000885590-11-000053#line-2","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001527497","owner_name":"Farmer Ronald Harold","owner_display_name":"Farmer Ronald Harold","owner_url":"/insider/0001527497","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":38.59,"price_display":"38.59","price_state":"stated","total_value":38590.0,"total_display":"38,590.00","total_whole":"38,590","shares_owned_after":6209.0,"shares_owned_after_display":"6,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-10","filed_date":"2011-08-11","scope":"insider"},{"id":8952083,"accession":"0000885590-11-000053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-11-000053","line_url":"/filing/0000885590-11-000053#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001527497","owner_name":"Farmer Ronald Harold","owner_display_name":"Farmer Ronald Harold","owner_url":"/insider/0001527497","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":38.66,"price_display":"38.66","price_state":"stated","total_value":38660.0,"total_display":"38,660.00","total_whole":"38,660","shares_owned_after":5209.0,"shares_owned_after_display":"5,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-09","filed_date":"2011-08-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":19,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000885590","name":"Valeant Pharmaceuticals International, Inc.","url":"/issuer/0000885590","role":"Director","n_filings":13,"first_seen":"2011-08-11","last_seen":"2015-10-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001527497","retrieved_at":"2026-08-26T02:45:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}